Robert J. Motzer
Memorial Sloan Kettering Cancer Center(US)Cornell University(US)Kettering University(US)
Publications by Year
Research Areas
Renal cell carcinoma treatment, Renal and related cancers, Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers, Testicular diseases and treatments
Most-Cited Works
- → Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma(2015)5,839 cited
- → Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma(2007)5,732 cited
- → Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma(2018)4,536 cited
- → Tumor mutational load predicts survival after immunotherapy across multiple cancer types(2019)4,299 cited
- → Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma(2007)3,641 cited
- → Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial(2008)3,002 cited